Laboratorio Reig Jofre S.A Market Cap ($221.39 Million)
Market Cap & Net Worth: Laboratorio Reig Jofre S.A (RJF)
Laboratorio Reig Jofre S.A market cap. Laboratorio Reig Jofre S.A (MC:RJF) has a market capitalization of $221.39 Million (€189.37 Million) as of November 7, 2026. Listed on the MC stock exchange, this Spain-based company holds position #15915 globally and #103 in its home market, demonstrating a -0.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laboratorio Reig Jofre S.A's stock price €2.56 by its total outstanding shares 81394434 (81.39 Million). Also see RJF operating cash flow for how efficiently the company converts equity into cash flow.
Laboratorio Reig Jofre S.A Market Cap History (2015–2026)
Laboratorio Reig Jofre S.A market cap history from 2015 to 2026. Data shows change from $299.87 Million to $243.61 Million (-3.08% CAGR). Check Laboratorio Reig Jofre S.A (RJF) stock price for real-time trading data and today's change.
Laboratorio Reig Jofre S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laboratorio Reig Jofre S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Laboratorio Reig Jofre S.A to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.70x
Laboratorio Reig Jofre S.A's market cap is 0.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.82x
Laboratorio Reig Jofre S.A's market cap is 22.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $299.87 Million | $156.91 Million | $8.75 Million | 1.91x | 34.27x |
| 2016 | $271.11 Million | $161.13 Million | $7.68 Million | 1.68x | 35.32x |
| 2017 | $205.74 Million | $167.98 Million | $8.83 Million | 1.22x | 23.30x |
| 2018 | $203.26 Million | $180.47 Million | $9.27 Million | 1.13x | 21.94x |
| 2019 | $227.92 Million | $200.21 Million | $4.94 Million | 1.14x | 46.12x |
| 2020 | $399.91 Million | $230.08 Million | $5.67 Million | 1.74x | 70.51x |
| 2021 | $299.06 Million | $236.23 Million | $5.09 Million | 1.27x | 58.73x |
| 2022 | $203.24 Million | $271.15 Million | $8.11 Million | 0.75x | 25.07x |
| 2023 | $211.59 Million | $316.09 Million | $9.41 Million | 0.67x | 22.49x |
| 2024 | $236.95 Million | $338.89 Million | $10.38 Million | 0.70x | 22.82x |
Competitor Companies of RJF by Market Capitalization
Companies near Laboratorio Reig Jofre S.A in the global market cap rankings as of November 7, 2026. Also see RJF current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Laboratorio Reig Jofre S.A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Laboratorio Reig Jofre S.A (2015–2026)
Market capitalization of Laboratorio Reig Jofre S.A from 2015 to today. Between 2015 and today, Laboratorio Reig Jofre S.A's market cap moved from $299.87 Million to $ 243.61 Million, with a yearly change of -3.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €243.61 Million | -0.39% |
| 2025 | €244.56 Million | +3.21% |
| 2024 | €236.95 Million | +11.99% |
| 2023 | €211.59 Million | +4.11% |
| 2022 | €203.24 Million | -32.04% |
| 2021 | €299.06 Million | -25.22% |
| 2020 | €399.91 Million | +75.46% |
| 2019 | €227.92 Million | +12.13% |
| 2018 | €203.26 Million | -1.21% |
| 2017 | €205.74 Million | -24.11% |
| 2016 | €271.11 Million | -9.59% |
| 2015 | €299.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Laboratorio Reig Jofre S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $221.39 Million USD |
| MoneyControl | $221.39 Million USD |
| MarketWatch | $221.39 Million USD |
| marketcap.company | $221.39 Million USD |
| Reuters | $221.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more